— Know what they know.
Not Investment Advice
Also trades as: EQRXW (NASDAQ) · $vol 0M

EQRX NASDAQ

EQRx, Inc.
1W: +0.0% 1M: +5.4% 3M: +4.5% 1Y: -57.9%
$2.34
Last traded 2023-11-09 — delisted
NASDAQ · Healthcare · Biotechnology · $1.1B mcap · 279M float · 1.61% daily turnover

Balance Sheet Trends

Total Assets
$1.5B -15.9% ▼
3Y CAGR: +320.7%
Total Liabilities
$66M -69.2% ▼
3Y CAGR: +33.1%
Shareholders Equity
$1.4B -8.3% ▼
Cash & Investments
$1.4B -16.6% ▼
3Y CAGR: +323.1%
Total Debt
$4M +13.5% ▲
3Y CAGR: -47.1%
Net Debt
-$490M +70.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$18M$490M$1.7B$494M
Short-Term Investments$0$0$0$905M
Cash & ST Investments$18M$490M$1.7B$1.4B
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$25K$3M$28M$29M
Total Current Assets$19M$492M$1.7B$1.4B
Property, Plant & Equip.$78K$8M$5M$6M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$4M$4M
Other Non-Current Assets$958K$669K$15M$16M
Total Non-Current Assets$1M$8M$23M$27M
Total Assets$20M$501M$1.7B$1.5B
— Liabilities —
Accounts Payable$1M$1M$8M$20M
Short-Term Debt$26M$2M$3M$2M
Deferred Revenue$0$0$0$0
Other Current Liabilities$1M$11M$29M$30M
Total Current Liabilities$28M$14M$40M$52M
Long-Term Debt$0$3M$272K$1M
Other Non-Current Liab.$4K$741M$175M$13M
Total Non-Current Liabilities$4K$744M$175M$14M
Total Liabilities$28M$759M$215M$66M
— Equity —
Common Stock$2K$3K$49K$49K
Retained Earnings-$9M-$258M-$358M-$528M
Accumulated OCI$0$0$1K-$148K
Total Stockholders Equity-$9M-$258M$1.5B$1.4B
Total Liabilities & Equity$20M$501M$1.7B$1.5B
— Key Metrics —
Total Debt$26M$5M$3M$4M
Net Debt$7M-$485M-$1.7B-$490M
Total Investments$0$0$4M$909M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms